Dealing with cancer screening in the COVID-19 era

Bibliographic Details
Main Author: Fagundes,Thales Pardini
Publication Date: 2021
Other Authors: Albuquerque,Ronniel Morais, Miranda,Diego Lopes Paim, Landeiro,Luciana Castro Garcia, Ayres,Gabriel Souza Fontes, Correia,Caenna Corrêa e, Nogueira-Rodrigues,Angélica
Format: Article
Language: eng
Source: Revista da Associação Médica Brasileira (Online)
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200086
Summary: SUMMARY OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19.
id AMB-1_32ac888a87398b6dbb7ab05821ab526b
oai_identifier_str oai:scielo:S0104-42302021000200086
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Dealing with cancer screening in the COVID-19 eraEarly detection of cancerNeoplasmsCoronavirus infectionsPandemicsSUMMARY OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19.Associação Médica Brasileira2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200086Revista da Associação Médica Brasileira v.67 suppl.1 2021reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.67.suppl1.20200889info:eu-repo/semantics/openAccessFagundes,Thales PardiniAlbuquerque,Ronniel MoraisMiranda,Diego Lopes PaimLandeiro,Luciana Castro GarciaAyres,Gabriel Souza FontesCorreia,Caenna Corrêa eNogueira-Rodrigues,Angélicaeng2021-08-19T00:00:00Zoai:scielo:S0104-42302021000200086Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2021-08-19T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Dealing with cancer screening in the COVID-19 era
title Dealing with cancer screening in the COVID-19 era
spellingShingle Dealing with cancer screening in the COVID-19 era
Fagundes,Thales Pardini
Early detection of cancer
Neoplasms
Coronavirus infections
Pandemics
title_short Dealing with cancer screening in the COVID-19 era
title_full Dealing with cancer screening in the COVID-19 era
title_fullStr Dealing with cancer screening in the COVID-19 era
title_full_unstemmed Dealing with cancer screening in the COVID-19 era
title_sort Dealing with cancer screening in the COVID-19 era
author Fagundes,Thales Pardini
author_facet Fagundes,Thales Pardini
Albuquerque,Ronniel Morais
Miranda,Diego Lopes Paim
Landeiro,Luciana Castro Garcia
Ayres,Gabriel Souza Fontes
Correia,Caenna Corrêa e
Nogueira-Rodrigues,Angélica
author_role author
author2 Albuquerque,Ronniel Morais
Miranda,Diego Lopes Paim
Landeiro,Luciana Castro Garcia
Ayres,Gabriel Souza Fontes
Correia,Caenna Corrêa e
Nogueira-Rodrigues,Angélica
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Fagundes,Thales Pardini
Albuquerque,Ronniel Morais
Miranda,Diego Lopes Paim
Landeiro,Luciana Castro Garcia
Ayres,Gabriel Souza Fontes
Correia,Caenna Corrêa e
Nogueira-Rodrigues,Angélica
dc.subject.por.fl_str_mv Early detection of cancer
Neoplasms
Coronavirus infections
Pandemics
topic Early detection of cancer
Neoplasms
Coronavirus infections
Pandemics
description SUMMARY OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200086
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000200086
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.67.suppl1.20200889
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.67 suppl.1 2021
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212835995418624